Commercialization Flashcards

1
Q

NEXAVAR Target label indication statement guided the planning of Phase 3 for registration

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NEXAVAR’s target Product Profile (TPP) is a key document summarizing NEXAVAR’s critical scientific, medical, regulatory and commerical success criteria

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is the drug commercialization stage defined (start -> end)?

A

1st regulatory approval -> patent expiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following metrics is NOT a key commercial metric?

A

Time to IND submission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What Program Management parameters are used to analyze drug commercialization programs, and make them comparable to each other for decision-making?

A
  • Scope
  • Time
  • Costs & resources
  • Risks & uncertainties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What combination of IP types is most evident (mostly used) in the R&D-based biosciences industry?

A

Patents and Trademarks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following commercialization activities are short-term, and are mostly realized suring the introduction phase of drug commercialization?

A

Post-approval commitments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NEXAVAR initial regulatory approval was based on how many clinical studies?

A

One Phase 2 & one Phase 3 study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main objective of the drug commercialization stage?

A

Maximize overall profitability of the marketed drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is not the role of Program Management in the Commercialization stage?

A

Setting & deciding on commercial objectives incl. sales and growth targets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key characteristics of patentability applied in the biosciences industry?

A
  • Novelty
  • Usefulness
  • Non-obviousness
  • Adequately described to public @ filing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which of the following combinations of commercialization activities describes critical trade-off decisions which need to be made during the growth phase of drug commercialization

A

Increase global sales & revenue AND reduce product & process-related costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Activities to reduce drug product- and process related (operational) costs are best organized as programs?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which life cycle management program to increase drug sales, revenue and market share has the highest level of success?

A

Geographical expansion of drug in approved clinical indication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is most likely NOT considered by drug companies once they decide on a drug price?

A

post-approval capital investments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the time span between the beginning of development to the end of commercialization?

A

20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the overall goal of drug commercialization?

A

Maximize profitability of approved drug

18
Q

Key commercial metrics

A

Time of 1st market introduction

% sales growth

Profit breakeven

Time-to-peak

19
Q

Major commercialization milestones

A
  • Regulatory approval (NDA, BLA, MAA, JNDA)
  • First launch in major geography
  • Regulatory submissions: Emerging Markets
  • Regulatory approvals in emerging markets
  • Annual % sales growth targets achieved
  • Global peak revenues achieved
  • First Patent Expiration in Major Geography
20
Q

4 measures to maximize profitability

A

Fulfill post-approval commitments

Increase global sales & revenue

Reduce product costs & operational costs

Extend patent protection

21
Q

PSP

A

Stands for Commercial Product Strategic Plan

  • Defined at EOP2 and prior to P3 registration studies
  • Defined key commercial metrics
22
Q

IP

A

Intellectual Property

Different types: Patents, Trademarks, Copyright, Trade Secrets

23
Q

IP has value only if:

A

underlying work is being developed & commercialized

24
Q

Patents

A

Protect ideas, discoveries, inventions, methods, data, designs, or practical implementations of algorithms

25
Copyrights
Authors and artists Concerned with unique artistic expression Provides right to reproduce, perform, distribute,, display, make derivative work
26
Trade secrets
protected know-how & information with economic vale only if kept secret
27
Trademarks
Brand names, logos used in commerce identifying origin of goods NEXAVAR HUCAL
28
What does the Project Manager own?
The process to achieve business results * Planning, organizing, directing and controlling of company resources (people, $, infrastructure, assets) for a project that has been established to achieve specific corporate business objectives
29
What's a project?
* Specific objective (tied to business goals) * Completed within defined specification * Defined starting and finishing dates * Constrained by limited resources & funding * Consumes resources (people, $, infrastructure * Performed by people
30
What's a program?
* Specific objective (tied to business goals) * Completed within defined specification * Defined starting and finish dates * Constrained by limited resources & funding * Consumes resources (people, $, infrastructure) * Performed by people
31
What are programs in drug commercialization?
* Post-approval commitments * Global sales & revenue growth * Product cost reductions * Operational cost reductions * Patent protection & extension
32
Differentiation
* What drug product features? * What drug features are critical? * What drug features do customers want?
33
Competition
* What competing drugs on the market? * What drug features do these have? * Are these what customers want?
34
Gloacl marketing is responsible for:
Sales & market share growth * Fulfill post-approval commitments * Increase global sales& revenue * Reduce product & operational costs * Extend patent protection
35
Marketing in Drug Discovery
* Drug Candidate features & attributes * Market Research on features & attributes * Indication, markets, market segments, target customers, reimbursement potential * Commercial $ value: drug candidate
36
Marketing in drug development
* Drug Candidate features & attributes * Detailed Market Research * Detailed: Indication, market segments, target customers, pricing & reimbursement * Commercial $ value: Drug label claims
37
Marketing in Drug Commercialization
* Commercial Product Strategic Plan (PSP) * Drug Product Life Cycle Management * Increase sales, revenue, and market share
38
Patent expirations:
Revenue losses due to key patent expirations
39
Generic Process is mainly -
CMC: 3-6 years, $4m
40
RITUXAN Biosimilar
REDITUX
41